Jade Biosciences, Inc. Debt Securities, Trading, Unrealized Gain
Jade Biosciences, Inc. (JBIO) reported Debt Securities, Trading, Unrealized Gain of $307.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2025-03-27
- Jade Biosciences, Inc. debt securities, trading, unrealized gain for the quarter ending 2024-09-30 was $307.00K, a 996.43% increase year-over-year.
- Jade Biosciences, Inc. debt securities, trading, unrealized gain for the quarter ending 2023-09-30 was $28.00K, a 100.00% increase year-over-year.
- Jade Biosciences, Inc. debt securities, trading, unrealized gain for the quarter ending 2023-03-31 was $265.00K.
- Jade Biosciences, Inc. debt securities, trading, unrealized gain for the quarter ending 2022-09-30 was $14.00K.
- Jade Biosciences, Inc. debt securities, trading, unrealized gain for fiscal 2023 was $703.00K.
| Period end | Debt Securities, Trading, Unrealized Gain 3 month | Debt Securities, Trading, Unrealized Gain 12 month |
|---|---|---|
| 2024-09-30 | $307.00K 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $703.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $28.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $265.00K 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $14.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |